Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection
- 1 January 1991
- Vol. 180 (1) , 294-305
- https://doi.org/10.1016/0042-6822(91)90034-9
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Molecular Characterization of a Neutralizing Domain of the Japanese Encephalitis Virus Structural GlycoproteinJournal of General Virology, 1989
- An Analysis of the Antibody Response against West Nile Virus E Protein Purified by SDS-PAGE Indicates that This Protein Does Not Contain Sequential Epitopes for Efficient Induction of Neutralizing AntibodiesJournal of General Virology, 1989
- Analyses of the terminal sequences of west nile virus structural proteins and of the in vitro translation of these proteins allow the proposal of a complete scheme of the proteolytic cleavages involved in their synthesisVirology, 1989
- Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cellsVirology, 1989
- Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 VirusJournal of General Virology, 1988
- Current Approaches to the Development of Dengue Vaccines and Related Aspects of the Molecular Biology of FlavivirusesThe Journal of Infectious Diseases, 1988
- Prospects for a virus non-structural protein as a subunit vaccineVaccine, 1988
- Protection of Mice Against Dengue 2 Virus Encephalitis by Immunization with the Dengue 2 Virus Non-structural Glycoprotein NS1Journal of General Virology, 1987
- Neutralizing (54K) and Non-neutralizing (54K and 48K) Monoclonal Antibodies against Structural and Non-structural Yellow Fever Virus Proteins Confer Immunity in MiceJournal of General Virology, 1986
- The hepatitis B virusNature, 1985